Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Solid pseudopapillary neoplasm of the pancreas with postoperative multiple liver metastases in an older woman: a case report.

Created on 11 Jul 2026

Authors

Yishan Lu, Nana Huang, Ruzhu Wang, Yuting Zhang, Haitao Duan, Ping Gao

Published in

Journal of gastrointestinal oncology. Volume 17. Issue 3. Pages 179. Jun 30, 2026. Epub Jun 05, 2026.

Abstract

Solid pseudopapillary neoplasm of the pancreas (SPN), also known as Frantz's tumor is a peculiar pancreatic neoplasm with an unclear pathogenesis. Early surgery often results in a curative effect; however, rare postoperative metastasis can occur. Currently, no standard systemic treatment strategy has been established for metastatic SPN. In this article, we report an older woman with SPN who developed postoperative multiple liver metastases and experienced rapid progression despite sequential systemic therapies.
A 68-year-old woman who underwent surgical resection of a SPN (approximately 44 months earlier) presented with multiple liver lesions despite having no obvious clinical findings. After laparoscopic distal pancreatectomy and splenectomy, multiple postoperative liver metastases were diagnosed by ultrasound-guided percutaneous liver biopsy, and a CTNNB1 gene mutation was detected. The patient received sequential palliative systemic therapies, however, the disease continued to progress, and she ultimately died 8 months later.
SPN is an extremely rare tumor with a relatively good prognosis. Complete surgical resection remains the mainstay of treatment; however, evidence for systemic therapy in unresectable or metastatic SPN remains limited. We report the case of a SPN patient with rare postoperative metastases and a poor prognosis, and describe the treatment course and systemic therapeutic strategy, which may serve as a reference for the management of similar cases.

PMID:
42434262
Bibliographic data and abstract were imported from PubMed on 11 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement